Investing Profile

Heather Preston

VCInvestor

Managing Partner at Pivotal BioVentures

pivotalbiovp.com/team-members...San Francisco, California
Photo of Heather Preston, Managing Partner at Pivotal bioVenture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
89 CONNECTIONS
University of Oxford Network
51 CONNECTIONS
New Enterprise Associates (NEA) Network
32 CONNECTIONS
cb
$100K - $5.0M
$1.5M
10
$300M
CompanyStageDateRound SizeTotal Raised
Arkuda Therapeutics
Series BFeb 2022$64M
$64M
Co-investors: Bruce Booth (Atlas Venture)
Avalyn Pharma
Series BApr 2020$36M
$36M
Co-investors: Robert Mittendorff (B Capital Group)
Akouos
Series BMar 2020$110M
$140M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Kush Parmar (5am Ventures)
Fusion Pharmaceuticals
Series BApr 2019$110M
$110M
Co-investors: Chau Khuong (OrbiMed)
Karuna Therapeutics
Series BMar 2019$68M
$110M
Co-investors: Robert Nelsen (ARCH Venture Partners), Steve Paul (Third Rock Ventures), James Healy (Sofinnova Investments)
Azura Ophthalmics
Series BOct 2017$16M
$16M
Entasis Therapeutics
Series BSep 2017$32M
$32M
Co-investors: Heather Behanna (SR One), Tracy Saxton (Dolby Family Ventures)
Alder Biopharmaceuticals
Series DApr 2012$38M
Series CDec 2007$40M
$78M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners)
Managing Partner Pivotal BioVentures2018 - Present
Partner and Managing Director TPG Biotech2005 - 2018
Entrepreneur In Residence New Enterprise Associates (NEA)2002 - 2003
Engagement Manager McKinsey & Company1997 - 2002
Gastroenterologist and Hepatologist University of California, San Francisco1996 - 1997
Internal Medicine Physician Massachusetts General Hospital1994 - 1996
Postdoctoral Research Fellow Harvard University1991 - 1994
University of Oxford MD Medicine
St Bartholomews Hospital Medical School, University of London B.Sc. Hons Biochemistry